Shares of Elite Pharmaceuticals, Inc. ELTP have lost 3.3% since the company reported its earnings for the quarter ended Dec. 31, 2024. This compares to the S&P 500 Index’s 1.2% gain over the same time ...

Elite Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development, manufacture, and sale of oral, controlled-release products, and generic pharmaceuticals. The company ...

In the second quarter of fiscal 2026, Elite Pharmaceuticals posted revenues of $36.3 million, up 92.4% year over year from $18.9 million, driven largely by the launch and rapid expansion of its ...

We are actively working to enhance your experience by translating more content. However, please be aware that the page you are about to visit has not yet been translated. We appreciate your ...

Repurchase of Common & Preferred Stk. Repurchase of Common & Preferred Stk.

Elite Pharmaceuticals Inc. Annual cash flow by MarketWatch. View ELTP net cash flow, operating cash flow, operating expenses and cash dividends.